POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to compare the efficacy and safety of POF, FOLFOX, and FOLFOX plus
paclitaxel(ip) as first-line treatment in AGC a phase II clinical trial.